Neumora Therapeutics logo
Neumora Therapeutics
NMRA | NASDAQ
Chart Builder DCF Calculator
$0.49
-$0.01 (-2.64%)
At close: Nov 9, 2026, 4:00 PM ET

Neumora Therapeutics Cash Flow Statement

Cash flow statement explained
TTM
Period Ending
Q2 2026
Jun 30, 2026
Q1 2026
Mar 31, 2026
Q4 2025
Dec 31, 2025
Q3 2025
Sep 30, 2025
Q2 2025
Jun 30, 2025
Q1 2025
Mar 31, 2025
Q4 2024
Dec 31, 2024
Q3 2024
Sep 30, 2024
Q2 2024
Jun 30, 2024
Q1 2024
Mar 31, 2024
Q4 2023
Dec 31, 2023
Q3 2023
Sep 30, 2023
Q2 2023
Jun 30, 2023
Q1 2023
Mar 31, 2023
Q4 2022
Dec 31, 2022
Q3 2022
Sep 30, 2022
Q2 2022
Jun 30, 2022
Q1 2022
Mar 31, 2022
Q4 2021
Dec 31, 2021
Q3 2021
Sep 30, 2021
Q2 2021
Jun 30, 2021
Q1 2021
Mar 31, 2021
-212.75M -222.39M -236.93M -236.3M -252.09M -258.06M -243.79M -293.7M -274.18M -254.02M -235.93M -155.34M -131.66M -123.49M -130.9M -129.73M -278.41M -265.05M -237.31M -230.34M -52.31M -35.3M
47K 59K 208K 356K 489K 630K 631K 640K 657K 668K 668K 649K 622K 605K 594K 578K 582K 553K 538K 470K 320K 195K
27.98M 27.96M 29.88M 32.37M 36.34M 41.94M 39.99M 36.14M 32.64M 22.42M 17.24M 13.98M 9.63M 8.84M 8.3M 6.72M 5.81M 5.12M 4.27M 3.88M 2.69M 1.63M
-28.55M -4.68M -508K 654K 20.48M 19.06M 19.76M 7.02M -18.89M -12.2M -8.32M 814K 2.27M 4.66M -5.7M -7.25M -4.71M -3.3M -202K 2.69M 205K -1.67M
29.25M 1.66M 841K -254K -362K -2.46M -2.41M 62M 62.3M 63.36M 63.64M -527K 428K 875K 14.06M 14.8M 171.19M 171.11M 158.04M 161.94M 4.76M 4.69M
– – – – – – – – – – – – – – – – – – – 220K 220K 220K
-25.04M -677K -437K -5M 19.95M 18.52M 22.64M 10.88M -19.75M -5.62M -8.9M -964K 784K -2.58M -6.95M -6.25M -4.55M -4.09M -961K 1.25M -1M -3.19M
-180.52M -193.4M -206.44M -208.83M -195.68M -199.43M -182.94M -184.04M -198.33M -173.19M -163.28M -142.2M -120.19M -115.75M -114.9M -113.88M -105.38M -92.36M -75.42M -62.58M -45.32M -31.76M
– – – -16K – – – -44K -81K -81K -117K -96K -189K -371K -511K -676K -763K -720K -817K -1.93M -1.71M -1.57M
158K 242K 171K 171K 84K – – – – – – – – – – – – – – – – –
-137K -39.52M -83.9M -190.66M -190.65M -170.8M -312.22M -225.4M -238.27M -253.39M -109.07M -137.1M -136.72M -195.42M -226.37M -178.27M -165.79M -72.43M – – – –
93.83M 162.63M 251.17M 216.69M 322.41M 294.41M 242.44M 272.72M 152.46M 170.41M 178.17M 179.87M 172.46M 113.73M 69.39M 29.3M – – – – – –
184K 1.08M 1.08M 896K 896K – – – – – – – – 2.48M -10.52M -10.52M -10.85M -13.3M – 990K 1.32M 1.29M
94.03M 124.43M 168.52M 27.08M 132.75M 123.6M -70.56M 41.92M -91.25M -88.43M 64.39M 42.68M 35.56M -79.59M -168.01M -160.17M -177.41M -86.45M -817K -939K -392K -283K
38.76M 57.16M 57.16M 18.26M 18.4M – – – – – – – – – – – – – – – – –
– – – – – – – – – – – – – – – – – – – – – –
– – – – – – – – – – – – – – – – – – – – – –
19.21M 19.65M 19.65M 1.88M 1.65M 1.65M 1.65M -225K 232.02M 232.32M 232.42M 234.28M 89.43M 91.22M 90.77M 88.62M 293.42M 291.98M 292.61M 292.91M 920K 280K
78.8M 87.96M 77.09M 33.89M 35.56M 19.76M 21.6M 5.55M 236.04M 233.68M 231.94M 259.25M 114.4M 116.2M 115.74M 88.55M 293.36M 291.92M 293.51M 305.67M 13.68M 13.04M
-7.69M 19M 39.17M -147.86M -27.37M -56.07M -231.89M -136.57M -53.54M -27.94M 133.05M 159.73M 29.77M -79.15M -167.17M -185.5M 10.57M 113.1M 217.27M 242.15M -32.03M -19M
-180.52M -193.4M -206.44M -208.84M -195.68M -199.43M -182.94M -184.08M -198.41M -173.27M -163.4M -142.3M -120.38M -116.12M -115.41M -114.56M -106.14M -93.08M -76.24M -64.51M -47.04M -33.33M
-208.5M -221.35M -236.32M -241.21M -232.01M -241.37M -222.93M -220.22M -231.05M -195.69M -180.64M -156.28M -130.01M -124.96M -123.71M -121.28M -111.95M -98.2M -80.51M -68.39M -49.73M -34.96M
-25K -25K -25K -16K – – – -44K -81K -81K -117K -96K -189K -343K -454K -562K -582K -553K -538K -470K n/a n/a
25K 25K 25K – – – – – – – – – – -28K -57K -114K -181K -167K -279K -1.46M n/a n/a
-180.55M -193.42M -206.47M -208.84M -195.68M -199.43M -182.94M -184.08M -198.41M -173.27M -163.4M -142.3M -120.38M -116.09M -115.35M -114.44M -105.96M -92.92M -75.96M -63.05M n/a n/a

© 2026 bestshares.com. All rights reserved.

All data is for informational purposes only. bestshares.com is not a broker, dealer, or registered investment adviser, and nothing on this site is a recommendation to buy or sell any security.